Therapeutic Strategies in Metabolic Syndrome

Description:

The metabolic syndrome is characterised by the presence in a particular individual of a number of metabolic risk factors that combine to put that patient at an increased risk of coronary artery disease, stroke, and diabetes. In this ground-breaking work, leading authorities in the field explain current thinking on how these risk factors may be managed, singly and in combination, enabling clinicians to formulate treatment plans that achieve better health outcomes for their patients.

Contents

1. Organizing lifestyle change in a community, S Dagogo-Jack
2. Dietary controversies and the metabolic syndrome: low carb, low fat, low calorie or low fructose? N Davis, N Tomuta, J Wiley-Rosett
3. An exercise prescription for the metabolic syndrome, R Bentley-Lewis, M Pendergrass
4. Impact of hypoglycemic agents on the metabolic syndrome, TK Thethi, S Singh, V Fonseca
5. Weight loss agents and the metabolic syndrome, W Cefalu
6. Blockade of the renin–angiotensin system on the metabolic syndrome: implications for diabetes prevention, P Deedwania
7. What is the appropriate lipid lowering therapy for the metabolic syndrome? O Ganda
8. Anti-inflammatory effects of insulin: implications for the metabolic syndrome? P Dandona,
A Chaudhuri, P Mohanty, H Ghanim
9. Anti-inflammatory drugs: suppressing the inflammatory state in obesity, V Fonseca, I Jialal
10. GLP-1 agonists and DDP-IV inhibitors and the metabolic syndrome, AH Stonehouse,
JH Holcombe, DM Kendall

Abbreviations
General index